SATELLOS BIOSCIENCE INC
MSLE · NASDAQ
Updated at 2026-10-15 04:58:22
- Today's High
- $7.14
- Today’s Low
- $6.51
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $7.14
- Previous Close
- $6.63
- Volume
- 43.82K
- Market Cap
- $227.22M
- P/E Ratio
- --
- EPS
- $-1.98
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- ROYAL BANK PLAZA, TORONTO, ON, CANADA, M5J 2J1
- Country
- CA
- Listing Date
- 2006-12-01
- Fiscal Year End
- December
- Shares Outstanding
- 20.84M
- CIK
- --
- Website
- satellos.com
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$11.85M
2026-03-31
$10.04M
2025-12-31
$7.64M
2025-09-30
$5.96M
Net Income
2026-06-30
-$11.42M
2026-03-31
-$9.76M
2025-12-31
-$7.3M
2025-09-30
-$5.82M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.56
2026-03-31
$-0.53
2025-12-31
$-0.50
2025-09-30
$-0.42
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$11.85M
2026-03-31
-$10.04M
2025-12-31
-$7.64M
2025-09-30
-$5.96M
Effective Tax Rate
2026-06-30
-0.37%
2026-03-31
-0.33%
2025-12-31
-0.8%
2025-09-30
-0.32%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $11.85M | $10.04M | $7.64M | $5.96M |
| Net Income | -$11.42M | -$9.76M | -$7.3M | -$5.82M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.56 | $-0.53 | $-0.50 | $-0.42 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$11.85M | -$10.04M | -$7.64M | -$5.96M |
| Effective Tax Rate | -0.37% | -0.33% | -0.8% | -0.32% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.